Circadian phase dependent pharmacokinetics of L-dopa, its main metabolites (3-OMD, HVA, DOPAC) and carbidopa in rats

被引:7
作者
Andre, MH [1 ]
Grignon, S [1 ]
Bruguerolle, B [1 ]
机构
[1] FAC MED MARSEILLE,LAB PHARMACOL MED & CLIN,F-13385 MARSEILLE 5,FRANCE
关键词
L-dopa; 3-OMD; HVA; DOPAC; carbidopa; rats; chronopharmacokinetics;
D O I
10.1111/j.1472-8206.1996.tb00586.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study aims to evaluate whether or not the kinetics of L-dopa, its main metabolites (3-O-methyldopa, 3-OMD, homovanilic acid, HVA and 3,4-dihydroxyphenylacetic acid, DOPAC) and carbidopa, vary according to the 24-hour scale in rats. Four groups of seven adult male Wistar AF EOPS rats were used for these experiments; each group received L-dopa (200 mg . kg(-1) ip) and carbidopa (20 mg . kg(-1) ip) at 1000, 1600, 2200 or 0400 hours. L-dopa, 3-OMD, DOPAC, HVA and carbidopa were simultaneously determined by specific ion-pair reversed-phase high performance liquid chromatography with electrochemical detection. A temporal variation of the kinetics of both L-dopa and carbidopa was demonstrated with higher plasma clearance and lower area under concentration curve after the administration at 2200 hours. Moreover, a temporal variation of the metabolism of L-dopa was indirectly documented by temporal variation in kinetics of 3-OMD, DOPAC and HVA.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 19 条
[1]   RECENT ADVANCES IN CHRONOPHARMACOKINETICS - METHODOLOGICAL PROBLEMS [J].
BRUGUEROLLE, B ;
LEMMER, B .
LIFE SCIENCES, 1993, 52 (23) :1809-1824
[2]   THE EFFECT OF CATECHOL-O-METHYL TRANSFERASE INHIBITION BY ENTACAPONE ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA IN HEALTHY-VOLUNTEERS [J].
KERANEN, T ;
GORDIN, A ;
HARJOLA, VP ;
KARLSSON, M ;
KORPELA, K ;
PENTIKAINEN, PJ ;
RITA, H ;
SEPPALA, L ;
WIKBERG, T .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (02) :145-156
[3]   CHRONOPHARMACOKINETICS - ARE THEY CLINICALLY RELEVANT [J].
LEMMER, B ;
BRUGUEROLLE, B .
CLINICAL PHARMACOKINETICS, 1994, 26 (06) :419-427
[4]  
LEMMER B, 1978, N-S ARCH PHARMACOL, V303, P257
[5]  
LEMMER B, 1981, TOP PHARM SCI, P49
[6]   THE EFFECTS OF CARBIDOPA DOSE AND TIME AND ROUTE OF ADMINISTRATION ON SYSTEMIC L-DOPA LEVELS IN RATS [J].
LEPPERT, PS ;
CORTESE, M ;
FIX, JA .
PHARMACEUTICAL RESEARCH, 1988, 5 (09) :587-591
[7]   CIRCADIAN-RHYTHMS IN BLOOD-PRESSURE AND NOREPINEPHRINE IN GENETICALLY HYPERTENSIVE AND NORMOTENSIVE RATS [J].
LEW, GM .
GENERAL PHARMACOLOGY, 1976, 7 (01) :35-40
[8]   AN INTERACTIVE PROGRAM FOR PHARMACOKINETIC MODELING [J].
LU, DR ;
MAO, FW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (05) :537-542
[10]   CIRCADIAN VARIATION IN THE MONOAMINE-OXIDASE ACTIVITY OF SPECIFIC RAT-BRAIN AREAS [J].
OWASOYO, JO ;
GIPSON, KD ;
SOLIMAN, KF ;
WALKER, CA .
JOURNAL OF INTERDISCIPLINARY CYCLE RESEARCH, 1984, 15 (03) :163-167